KBRA assigns preliminary ratings to 102 classes of mortgage pass-through certificates from Sequoia Mortgage Trust 2026-4 (SEMT 2026-4), a $742.1 million prime RMBS transaction. The pool is comprised ...

KBRA assigns preliminary ratings to 23 classes of mortgage pass-through certificates from Sequoia Mortgage Trust 2026-MED1 (SEMT 2026-MED1). SEMT 2026-MED1 represents the first publicly-rated RMBS ...

A quiet warning signal for Crohn’s disease may show up in your blood years before your stomach ever hurts. That is the message from new research out of Sinai Health, where scientists report a blood ...

Financial advisers in the UK are evolving their retirement advice approaches to better navigate client planning needs amid regulatory and policy changes, a report from BNY Investments and NextWealth h ...

KBRA assigns preliminary ratings to 10 classes of mortgage-backed notes from New Residential Mortgage Loan Trust 2026-NQM4 (NRMLT 2026-NQM4), a $496.3 million non-prime RMBS transaction sponsored by ...

KBRA assigns preliminary ratings to four classes of notes issued by Upstart Securitization Trust 2026-1 ("UPST 2026-1"), a $292.21 million consumer loan ABS securitization collateralized by unsecured ...

A slow but significant change has occurred in how healthcare professionals and organizations are expected to respond when something has gone wrong in a patient’s care. In 2001, the US accreditation ...

Sometimes waiting for symptoms to appear may be too late when it comes to detecting cancer. Dr Vass shares tests that can help with early detection.

Creator with 900K followers says TikTok declined after U.S. merge, citing glitches, lower payouts, and algorithm changes.

After a long trail race, some of your red blood cells may not bend the way they should. That matters because red blood cells have a tight job description.

KBRA assigns preliminary ratings to four classes of notes issued by OneMain Direct Auto Receivables Trust 2026-1 ...

MoonLake Immunotherapeutics (NASDAQ:MLTX) is among the 12 Most Promising Small-Cap Stocks According to Wall Street Analysts. MoonLake Immunotherapeutics (NASDAQ:MLTX) is placed eighth on our list of ...